{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:48:46Z","timestamp":1793911726621,"version":"4.8.0"},"reference-count":326,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","award":["2023QNA045"],"award-info":[{"award-number":["2023QNA045"]}],"id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J08189"],"award-info":[{"award-number":["2024J08189"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neo.2026.101348","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:09:54Z","timestamp":1786604994000},"page":"101348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Decoding tumor immune microenvironment heterogeneity by single-cell and spatial multi-omics: From immunotherapy resistance to translational biomarkers"],"prefix":"10.1016","volume":"80","author":[{"given":"Tingting","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0001","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nature Cancer"},{"key":"10.1016\/j.neo.2026.101348_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.754196","article-title":"Targeting myeloid-derived suppressor cells to enhance the antitumor efficacy of immune checkpoint blockade therapy","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.neo.2026.101348_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184043","article-title":"Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response","volume":"135","author":"Tao","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0004","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ccell.2023.07.011","article-title":"Neoadjuvant immune checkpoint blockade: a window of opportunity to advance cancer immunotherapy","volume":"41","author":"Topalian","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011377","article-title":"Acasunlimab, an Fc-inert PD-L1\u00d74-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects","volume":"13","author":"Capello","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"22","key":"10.1016\/j.neo.2026.101348_bib0007","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0008","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-025-02077-6","article-title":"Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma","volume":"57","author":"Liang","year":"2025","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0009","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/0008-5472.CAN-20-1674","article-title":"Enhanced efficacy of simultaneous PD-1 and PD-L1 immune checkpoint blockade in high-grade serous ovarian cancer","volume":"81","author":"Wan","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","article-title":"Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0011","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17474124.2021.1864325","article-title":"BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0012","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejso.2022.12.006","article-title":"Immunonutrition and prehabilitation in pancreatic cancer surgery: a new concept in the era of ERAS\u00ae and neoadjuvant treatment","volume":"49","author":"De Luca","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0013","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/ph14070677","article-title":"Hacking pancreatic cancer: present and future of personalized medicine","volume":"14","author":"Di Federico","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.euo.2023.07.003","article-title":"Real-world outcome of patients with advanced renal cell carcinoma and intermediate- or poor-risk international metastatic renal cell carcinoma database consortium criteria treated by immune-oncology combinations: differential effectiveness by risk group?","volume":"7","author":"Santoni","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0015","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2217\/fon-2020-0989","article-title":"DNA damage response alterations in gastric cancer: knocking down a new wall","volume":"17","author":"Ricci","year":"2021","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71746-z","article-title":"Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis","volume":"14","author":"Vitale","year":"2024","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010311","article-title":"Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types","volume":"13","author":"Gandara","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0018","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","article-title":"Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours","volume":"24","author":"Holder","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The challenges of tumor mutational burden as an immunotherapy biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.neo.2026.101348_bib0020","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-23-3403","article-title":"Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer","volume":"30","author":"Lenis","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-025-01732-z","article-title":"The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives","volume":"18","author":"Sun","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0022","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s43856-024-00687-5","article-title":"Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers","volume":"4","author":"Barnett","year":"2024","journal-title":"Commun. Med."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0023","first-page":"162","article-title":"Immune checkpoint inhibitor therapy in locally advanced MSI GI malignancies","volume":"22","author":"Harrold","year":"2024","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0024","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.annonc.2023.05.010","article-title":"Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability","volume":"34","author":"Ratovomanana","year":"2023","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1470-2045(22)00783-5","article-title":"Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study","volume":"24","author":"Wang","year":"2023","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0026","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12885-023-10920-4","article-title":"SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy","volume":"23","author":"Zheng","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0027","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/08923973.2025.2504906","article-title":"Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance","volume":"47","author":"Gill","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"699","key":"10.1016\/j.neo.2026.101348_bib0028","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh8005","article-title":"Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer","volume":"15","author":"Herzog","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0029","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41467-024-47425-y","article-title":"Molecular patterns of resistance to immune checkpoint blockade in melanoma","volume":"15","author":"Lauss","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101348_bib0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2019.03.006","article-title":"Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance","volume":"220","author":"Li","year":"2020","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0032","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0033","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nature Immunol."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0034","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/neuonc\/noae126","article-title":"IL-13R\u03b12\/TGF-\u03b2 bispecific CAR-T cells counter TGF-\u03b2-mediated immune suppression and potentiate anti-tumor responses in glioblastoma","volume":"26","author":"Hou","year":"2024","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0035","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.ymthe.2024.08.019","article-title":"Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8(+) T and CAR-T cells","volume":"32","author":"Jo","year":"2024","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0036","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41587-023-02060-8","article-title":"IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases","volume":"42","author":"Zhao","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0037","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jhep.2024.12.016","article-title":"Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma","volume":"82","author":"Cappuyns","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.neo.2026.101348_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): non-genetic tumor heterogeneity and immune microenvironment: emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol. Therap."},{"issue":"6282","key":"10.1016\/j.neo.2026.101348_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12916-023-02866-y","article-title":"Single-cell sequencing reveals the immune microenvironment landscape related to anti-PD-1 resistance in metastatic colorectal cancer with high microsatellite instability","volume":"21","author":"Wu","year":"2023","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0041","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1038\/s41467-024-52977-0","article-title":"Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"issue":"6574","key":"10.1016\/j.neo.2026.101348_bib0042","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0043","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0044","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","article-title":"Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer","volume":"40","author":"Huang","year":"2022","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/0008-5472.CAN-23-1448","article-title":"Spatial and single-cell transcriptomics reveal a cancer-associated fibroblast subset in HNSCC that restricts infiltration and antitumor activity of CD8+ T cells","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"issue":"7948","key":"10.1016\/j.neo.2026.101348_bib0046","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0047","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41588-025-02351-7","article-title":"Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer","volume":"57","author":"Aung","year":"2025","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0048","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1038\/s41598-022-13855-1","article-title":"Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer","volume":"12","author":"Liang","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0049","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00262-025-04189-8","article-title":"Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer","volume":"74","author":"Wei","year":"2025","journal-title":"Cancer Immunol. Immunther."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012330","article-title":"SPP1(high) macrophage-induced T-cell stress promotes colon cancer liver metastasis through SPP1\/CD44\/PI3K\/AKT signaling","volume":"13","author":"Ding","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0051","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1038\/s41467-021-25962-0","article-title":"Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer","volume":"12","author":"Hammerl","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101348_bib0052","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0053","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2026.101348_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0055","article-title":"Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence","volume":"5","author":"Dai","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107066","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer","volume":"161","author":"Guo","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102463","article-title":"Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing","volume":"56","author":"Hao","year":"2022","journal-title":"Redox. Biol."},{"key":"10.1016\/j.neo.2026.101348_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117480","article-title":"Unlocking the potential of extracellular vesicle circRNAs in breast cancer: from molecular mechanisms to therapeutic horizons","volume":"180","author":"Fang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"7990","key":"10.1016\/j.neo.2026.101348_bib0059","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-023-06733-x","article-title":"Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer","volume":"624","author":"Zhou","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54569-4","article-title":"Human single cell RNA-sequencing reveals a targetable CD8(+) exhausted T cell population that maintains mouse low-grade glioma growth","volume":"15","author":"Barakat","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1453","article-title":"Single-cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer","volume":"13","author":"Guo","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.985187","article-title":"Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR\/BCR clonal expansion in a relapsed ovarian cancer patient","volume":"13","author":"Ren","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0063","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/j.gastro.2021.06.025","article-title":"Interferon-gamma-producing CD8(+) tissue resident memory T cells are a targetable hallmark of immune checkpoint inhibitor-colitis","volume":"161","author":"Sasson","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0064","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1038\/s41467-021-26614-z","article-title":"Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface","volume":"12","author":"Hunter","year":"2021","journal-title":"Nat. Commun."},{"issue":"7948","key":"10.1016\/j.neo.2026.101348_bib0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0066","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1038\/s41467-025-60448-3","article-title":"Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment","volume":"16","author":"Feng","year":"2025","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.neo.2026.101348_bib0067","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/j.cell.2022.10.006","article-title":"Systemic vaccination induces CD8(+) T cells and remodels the tumor microenvironment","volume":"185","author":"Baharom","year":"2022","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.neo.2026.101348_bib0068","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-22-3034","article-title":"Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear cell renal cell carcinoma","volume":"83","author":"Davidson","year":"2023","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0069","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007230","article-title":"Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8(+) T cell infiltration and functional transition","volume":"11","author":"Yu","year":"2023","journal-title":"J. ImmunOther Cancer"},{"issue":"17","key":"10.1016\/j.neo.2026.101348_bib0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg0654","article-title":"Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy","volume":"9","author":"Chen","year":"2023","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0071","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","article-title":"Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer","volume":"163","author":"Datta","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0072","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10020-022-00475-8","article-title":"Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction","volume":"28","author":"Song","year":"2022","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0073","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","article-title":"Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics","volume":"12","author":"Tirier","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0074","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0075","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","article-title":"Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer","volume":"12","author":"McAndrews","year":"2022","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0076","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200898R","article-title":"Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing","volume":"36","author":"Shi","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.neo.2026.101348_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0078","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.7150\/thno.68972","article-title":"FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0079","article-title":"A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML","volume":"5","author":"Guo","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0080","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","article-title":"Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47","volume":"5","author":"Huang","year":"2024","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0081","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/neuonc\/noad257","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma","volume":"26","author":"Peshoff","year":"2024","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0082","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.ccell.2025.05.013","article-title":"CSF1R(+) myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma","volume":"43","author":"Stahl","year":"2025","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0083","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","article-title":"Hypoxia induces HIF1\u03b1-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy","volume":"13","author":"Ma","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0084","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231106","article-title":"Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"222","author":"Robles-Ote\u00edza","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jare.2024.12.026","article-title":"FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A\/YTHDF3\/PDK1 axis under hypoxic conditions","volume":"76","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neo.2026.101348_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105003","article-title":"Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer","volume":"101","author":"Di Modugno","year":"2024","journal-title":"EBioMed."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0087","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1097\/JS9.0000000000002568","article-title":"Tertiary lymphoid structures signature predicts prognosis and clinical benefits from neoadjuvant chemotherapy and PD-1 blockade in colorectal adenocarcinoma","volume":"111","author":"Guo","year":"2025","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0088","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115572","article-title":"Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy","volume":"225","author":"Vion","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114392","article-title":"Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy","volume":"43","author":"Quek","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2026.101348_bib0091","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","article-title":"Insights gained from single-cell analysis of immune cells in the tumor microenvironment","volume":"39","author":"Ren","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0092","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0093","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","article-title":"Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity","volume":"39","author":"Hutton","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0094","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1158\/0008-5472.CAN-25-0079","article-title":"Tumor-associated macrophages produce PGE2 to promote CD8+ T-cell exhaustion and drive resistance to PD-L1 blockade in microsatellite-stable colorectal cancer","volume":"86","author":"Fumet","year":"2026","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41416-025-03088-0","article-title":"Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13\u2009+\u2009T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy","volume":"133","author":"Sakai","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0096","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/0008-5472.CAN-24-1509","article-title":"Spatial and single-cell analyses reveal heterogeneity of DNAM-1 receptor-ligand interactions that instructs intratumoral \u03b3\u03b4t-cell activity","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0097","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41421-025-00811-2","article-title":"Spatially resolved C1QC(+) macrophage-CD4(+) T cell niche in colorectal cancer microenvironment: implications for immunotherapy response","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Discov."},{"issue":"8024","key":"10.1016\/j.neo.2026.101348_bib0098","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","article-title":"Tumour vasculature at single-cell resolution","volume":"632","author":"Pan","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0099","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12032-023-02226-z","article-title":"Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy","volume":"40","author":"Alzamami","year":"2023","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0100","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1038\/s41467-021-27599-5","article-title":"Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment","volume":"12","author":"Dinh","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8(+) T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0102","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.7150\/thno.108925","article-title":"Single-nucleus RNA sequencing and spatial transcriptomics reveal an immunosuppressive tumor microenvironment related to metastatic dissemination during pancreatic cancer liver metastasis","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0103","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0104","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.7150\/thno.94537","article-title":"Targeting tumor cell-to-macrophage communication by blocking vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00428-024-03746-3","article-title":"Molecular pathological classification of colorectal cancer-an update","volume":"484","author":"Dunne","year":"2024","journal-title":"Virchows Arch."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0106","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0107","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","article-title":"Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1(+) T lymphocyte niches through a feed-forward loop","volume":"40","author":"Hua","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2026.101348_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105348","article-title":"Single-cell profiling of tumor-infiltrating TCF1\/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures\/organs and a superior prognosis in oral cancer","volume":"119","author":"Peng","year":"2021","journal-title":"Oral Oncol."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0109","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.ccell.2023.08.001","article-title":"Tumor immunogenicity dictates reliance on TCF1 in CD8(+) T cells for response to immunotherapy","volume":"41","author":"Escobar","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0110","article-title":"Pan-cancer mapping of single CD8(+) T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity","volume":"5","author":"Tooley","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0111","article-title":"Terminally exhausted CD8(+) T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0112","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0113","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41588-025-02193-3","article-title":"High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer","volume":"57","author":"Oliveira","year":"2025","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.neo.2026.101348_bib0114","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.2024024590","article-title":"Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma","volume":"144","author":"John","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0115","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0116","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","article-title":"Multimodal mapping of the tumor and peripheral blood immune landscape in Human pancreatic cancer","volume":"1","author":"Steele","year":"2020","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0117","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0118","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"issue":"7868","key":"10.1016\/j.neo.2026.101348_bib0119","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neo.2026.101348_bib0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jare.2025.03.021","article-title":"Intestinal tissue-resident memory T cells: characteristics, spatial heterogeneity, age-related dynamics, and roles in disease regulation","volume":"79","author":"Yan","year":"2026","journal-title":"J. Adv. Res."},{"issue":"8009","key":"10.1016\/j.neo.2026.101348_bib0121","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41586-024-07251-0","article-title":"Immune microniches shape intestinal T(reg) function","volume":"628","author":"Gu","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0122","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.immuni.2026.03.009","article-title":"Spatial organization of tissue-resident memory T cells","volume":"59","author":"Burn","year":"2026","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0123","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ccell.2021.05.016","article-title":"Innate immune cells in the tumor microenvironment","volume":"39","author":"Li","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0124","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ccell.2025.12.021","article-title":"Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth","volume":"44","author":"Mateus-Tique","year":"2026","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0125","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1038\/s41467-024-49189-x","article-title":"TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer","volume":"15","author":"Anandhan","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0126","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011319","article-title":"Malevolent alliance of MYBL2(hi) cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer","volume":"13","author":"Chen","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0127","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013027","article-title":"Macrophage CCL7 promotes resistance to immunotherapy for colorectal cancer by regulating the infiltration of macrophages and CD8(+) T cells","volume":"13","author":"Chen","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00018-025-06056-2","article-title":"CA9+\u2009cancer-associated fibroblasts cooperate with SPP1+\u2009tumor-associated macrophages driving immune resistance in triple-negative breast cancer","volume":"83","author":"Ma","year":"2026","journal-title":"Cell Mol. Life Sci."},{"issue":"28","key":"10.1016\/j.neo.2026.101348_bib0129","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/s41388-025-03425-w","article-title":"USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells","volume":"44","author":"You","year":"2025","journal-title":"Oncogene"},{"issue":"6679","key":"10.1016\/j.neo.2026.101348_bib0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.adg1955","article-title":"Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape","volume":"383","author":"Sharma","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0131","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0132","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0133","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0134","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1158\/0008-5472.CAN-24-4916","article-title":"SPP1 drives colorectal cancer liver metastasis and immunotherapy resistance by stimulating CXCL12 production in cancer-associated fibroblasts","volume":"86","author":"Liu","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101348_bib0135","article-title":"ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0136","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","article-title":"Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis","volume":"161","author":"Nallasamy","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0137","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12964-025-02297-7","article-title":"You B: er\u03b1-dependent crosstalk between macrophages and cancer cells potentiates vasculogenic mimicry and M2 macrophage polarization in bladder cancer","volume":"23","author":"Liu","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0138","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13046-022-02499-8","article-title":"Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis","volume":"41","author":"Qiu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0139","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12026-024-09479-4","article-title":"The role of tumor-associated macrophages in the radioresistance of esophageal cancer cells via regulation of the VEGF-mediated angiogenic pathway","volume":"72","author":"Sun","year":"2024","journal-title":"Immunol. Res."},{"issue":"6695","key":"10.1016\/j.neo.2026.101348_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0141","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41590-025-02259-8","article-title":"Simultaneous STING and lymphotoxin-\u03b2 receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity","volume":"26","author":"Sawada","year":"2025","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0142","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1346","article-title":"Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy","volume":"13","author":"Wang","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0143","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.7150\/ijbs.113737","article-title":"Interferon regulatory factor 4 recruits immature B cells to signal tertiary lymphoid structure immaturity and progression of clear cell renal cell carcinoma","volume":"21","author":"Zhou","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"13","key":"10.1016\/j.neo.2026.101348_bib0144","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1158\/0008-5472.CAN-06-0889","article-title":"CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo","volume":"66","author":"Chung","year":"2006","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0145","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood-2008-05-157396","article-title":"Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1","volume":"112","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.neo.2026.101348_bib0146","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.778329","article-title":"Colorectal cancer-associated immune exhaustion involves T and B lymphocytes and conventional NK cells and correlates with a shorter overall survival","volume":"12","author":"Sorrentino","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0147","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115364","article-title":"DA-DRD5 signaling reprograms B cells to promote CD8(+) T cell-mediated antitumor immunity","volume":"44","author":"Wu","year":"2025","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0148","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/CJI.0b013e3181ee6ba9","article-title":"Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody","volume":"33","author":"Zhou","year":"2010","journal-title":"J. ImmunOther"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0149","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2023.12.012","article-title":"Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer","volume":"42","author":"Shiao","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0150","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy","volume":"166","author":"Hu","year":"2024","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0151","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","article-title":"CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis","volume":"42","author":"Zhang","year":"2024","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0152","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217917","article-title":"Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer","volume":"631","author":"He","year":"2025","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0154","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2024.09.044","article-title":"CXCL12(+) tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma","volume":"82","author":"Lu","year":"2025","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0156","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","article-title":"A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling","volume":"30","author":"Qian","year":"2020","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0157","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2026.101348_bib0158","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118389","article-title":"Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways","volume":"259","author":"Giatromanolaki","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055146","article-title":"Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer","volume":"8","author":"Ino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2026.101348_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112282","article-title":"Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape","volume":"138","author":"Shang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neo.2026.101348_bib0161","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1009789","article-title":"Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0162","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1950953","article-title":"Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity","volume":"10","author":"Ziani","year":"2021","journal-title":"Oncoimmunology"},{"issue":"50","key":"10.1016\/j.neo.2026.101348_bib0163","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0164","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23778","article-title":"Cancer-associated fibroblasts-derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD-L1","volume":"38","author":"Feng","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109674","article-title":"Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis","volume":"27","author":"Xiong","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.neo.2026.101348_bib0166","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1635915","article-title":"CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0167","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0168","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.ymthe.2023.09.010","article-title":"CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-\u03bab\/SDF-1\u03b1 axis to enhance efficacy against pancreatic cancer","volume":"31","author":"Sun","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neo.2026.101348_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116326","article-title":"NGR-modified cancer-associated fibroblast-derived exosomes deliver resveratrol to inhibit CXCR2\/NF-\u03bab signaling in myeloid-derived suppressor cells and reverse immune suppression in liver cancer","volume":"174","author":"Ding","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0170","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00262-022-03156-x","article-title":"VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients","volume":"71","author":"Khan","year":"2022","journal-title":"Cancer Immunol. Immunther."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0171","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2300882","article-title":"Extracellular vesicles released by cancer-associated fibroblast-induced myeloid-derived suppressor cells inhibit T-cell function","volume":"13","author":"Ramil","year":"2024","journal-title":"Oncoimmunology"},{"issue":"14","key":"10.1016\/j.neo.2026.101348_bib0172","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/bloodadvances.2024015616","article-title":"Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix-producing cancer-associated fibroblasts","volume":"9","author":"Dessauge","year":"2025","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0173","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00262-026-04348-5","article-title":"Association of CCL21(+) CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma","volume":"75","author":"Li","year":"2026","journal-title":"Cancer Immunol. Immunther."},{"key":"10.1016\/j.neo.2026.101348_bib0174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2026.02.003","article-title":"Persistent spatial immune responses in glioblastoma following oncolytic virus therapy","volume":"89","author":"Ma","year":"2026","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0175","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70145","article-title":"Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma","volume":"9","author":"Leivonen","year":"2025","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0176","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12967-022-03510-8","article-title":"Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer","volume":"20","author":"Peng","year":"2022","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0177","article-title":"Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics","volume":"4","author":"Qin","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0178","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12964-025-02162-7","article-title":"LAMA4(+) CD90(+) eCAFs provide immunosuppressive microenvironment for liver cancer through induction of CD8(+) T cell senescence","volume":"23","author":"Zhang","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0179","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-023-01218-y","article-title":"Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence","volume":"15","author":"Zhang","year":"2023","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/path.6395","article-title":"Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer","volume":"265","author":"Lu","year":"2025","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0181","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-25-2871","article-title":"Targeting LRRC15 in cancer-associated fibroblasts modifies the extracellular matrix and enhances tumor immune responses to suppress lung cancer progression","volume":"86","author":"Qi","year":"2026","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0182","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1186\/s12967-025-07307-3","article-title":"Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-tgf\u03b2 axis and immune suppression in aggressive thyroid cancer","volume":"23","author":"Udinotti","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0183","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113998","article-title":"Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment","volume":"385","author":"Wu","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.neo.2026.101348_bib0184","article-title":"Single-cell analysis reveals the COL11A1(+) fibroblasts are cancer-specific fibroblasts that promote tumor progression","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0185","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","article-title":"Single-cell meta-analyses reveal responses of tumor-reactive CXCL13(+) T cells to immune-checkpoint blockade","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0186","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009603","article-title":"Intratumoral CXCL13(+) CD160(+) CD8(+) T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer","volume":"12","author":"Wang","year":"2024","journal-title":"J. ImmunOther Cancer"},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0187","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.7150\/thno.90627","article-title":"Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-\u03b2 activity and CD8(+) T-cell infiltration in breast cancer","volume":"14","author":"Honda","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0188","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."},{"issue":"28","key":"10.1016\/j.neo.2026.101348_bib0189","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1038\/s41388-025-03359-3","article-title":"Fibroblast Activation protein (FAP)(+) cancer-associated fibroblasts induce macrophage M2-like polarization via the fibronectin 1-integrin \u03b15\u03b21 axis in breast cancer","volume":"44","author":"Chen","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13046-025-03510-8","article-title":"COL10A1(+) fibroblasts promote colorectal cancer metastasis and M2 macrophage polarization with pan-cancer relevance","volume":"44","author":"Hu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0191","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0192","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1158\/1078-0432.CCR-22-2041","article-title":"Colorectal cancer metastases in the liver establish immunosuppressive spatial networking between tumor-associated SPP1+ macrophages and fibroblasts","volume":"29","author":"Sathe","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0193","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41588-025-02380-2","article-title":"TGF-\u03b2 builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1(+) macrophages","volume":"57","author":"Henriques","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neo.2026.101348_bib0194","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111462","article-title":"CAF-secreted LOX promotes PD-L1 expression via histone lactylation and regulates tumor EMT through tgf\u03b2\/IGF1 signaling in gastric cancer","volume":"124","author":"Li","year":"2024","journal-title":"Cell Signal."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","article-title":"Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03bab and TGF-\u03b22 signaling","volume":"29","author":"Lin","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0196","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2144669","article-title":"Chemokine switch regulated by TGF-\u03b21 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy","volume":"11","author":"Vienot","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0197","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111929","article-title":"Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer","volume":"42","author":"Ozato","year":"2023","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0198","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76298-w","article-title":"SPP1+\u2009macrophages and FAP+\u2009fibroblasts promote the progression of pMMR gastric cancer","volume":"14","author":"Su","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0199","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/2159-8290.CD-25-1774","article-title":"A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancer","volume":"16","author":"Tran","year":"2026","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0200","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.devcel.2025.01.014","article-title":"STAT3-controlled CHI3L1\/SPP1 positive feedback loop demonstrates the spatial heterogeneity and immune characteristics of glioblastoma","volume":"60","author":"Yu","year":"2025","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0201","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41467-025-62132-y","article-title":"Metabolism archetype cancer cells induce protumor TREM2(+) macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma","volume":"16","author":"Chu","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12906-025-05020-8","article-title":"Qingrehuoxue formula enhances anti-PD-1 immunotherapy in NSCLC by remodeling the tumor immune microenvironment via TREM2 signaling","volume":"25","author":"Li","year":"2025","journal-title":"BMC Complement. Med. Ther."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0203","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12967-024-05489-w","article-title":"HMGB1\/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4\/Akt signaling","volume":"22","author":"Qiu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0204","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13046-024-03124-6","article-title":"Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancer","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.neo.2026.101348_bib0205","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501027","article-title":"Targeted reprogramming of TREM2-positive macrophages and MRI-guided immune monitoring in colorectal cancer using CSF1R@Mn@MPDA-Antitrem2 nanoplatform","volume":"14","author":"Zhao","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-023-01830-x","article-title":"Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer","volume":"22","author":"Chen","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0207","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2025.01.244","article-title":"TREM2 Depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1\u03b2(+) macrophages","volume":"168","author":"Yang","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neo.2026.101348_bib0208","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1502936","article-title":"Optimized BCMA\/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0209","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006896","article-title":"CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity","volume":"11","author":"Salehi-Rad","year":"2023","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.neo.2026.101348_bib0210","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+)trm cell response to PD-1 blockade in gastric cancer","volume":"23","author":"Hu","year":"2023","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0211","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/cas.16371","article-title":"CXCL9 and CXCL13 shape endometrial cancer immune-activated microenvironment via tertiary lymphoid structure formation","volume":"116","author":"Nagase","year":"2025","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0212","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0213","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0214","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","article-title":"PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Therapy"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-024-02917-y","article-title":"Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer","volume":"132","author":"Wang","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0216","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1038\/s41467-024-53262-w","article-title":"Spatial dynamics of CD39(+)CD8(+) exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer","volume":"15","author":"Tanoue","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0217","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009140","article-title":"Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction","volume":"13","author":"Bernatowicz","year":"2025","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.neo.2026.101348_bib0218","article-title":"Association of baseline tumor-specific neoantigens and CD8(+) T-cell infiltration with immune-related adverse events secondary to immune checkpoint inhibitors","volume":"8","author":"Kerepesi","year":"2024","journal-title":"JCo Precis. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0219","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008056","article-title":"Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4(+) na\u00efve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma","volume":"12","author":"Kovacsovics-Bankowski","year":"2024","journal-title":"J. ImmunOther Cancer"},{"issue":"24","key":"10.1016\/j.neo.2026.101348_bib0220","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.3390\/cancers14246095","article-title":"Predictive value of baseline FDG-PET\/CT for the durable response to immune checkpoint inhibition in NSCLC patients using the morphological and metabolic features of primary tumors","volume":"14","author":"Kudura","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2026.101348_bib0221","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2021.01.036","article-title":"Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy","volume":"148","author":"Groeneveld","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2026.101348_bib0222","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217278","article-title":"Revisiting the CXCL13\/CXCR5 axis in the tumor microenvironment in the era of single-cell omics: implications for immunotherapy","volume":"605","author":"Gu","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0223","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16279","article-title":"Beyond T cell toxicity - intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: a two-case series and literature review","volume":"31","author":"Otto","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neo.2026.101348_bib0224","article-title":"High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101348_bib0225","article-title":"SRSF3 Promotes angiogenesis in colorectal cancer by splicing SRF","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0226","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s00432-022-04300-x","article-title":"Non-invasive early prediction of immune checkpoint inhibitor efficacy in non-small-cell lung cancer patients using on-treatment serum CRP and NLR","volume":"149","author":"Matsuzawa","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0227","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/07357907.2025.2557004","article-title":"Early changes in lymphocyte\/monocyte ratio on treatment as a prognostic marker to predict overall survival in patients with advanced cancer treated with Immune checkpoint inhibitors","volume":"43","author":"Patel","year":"2025","journal-title":"Cancer Invest."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0228","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.euo.2023.08.009","article-title":"Early on-treatment circulating tumor DNA measurements and response to immune checkpoint inhibitors in advanced urothelial cancer","volume":"7","author":"Tolmeijer","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0229","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cell.2020.07.017","article-title":"Therapy-induced evolution of Human lung cancer revealed by single-cell RNA sequencing","volume":"182","author":"Maynard","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0230","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1652538","article-title":"The impact of CTLA-4 blockade and interferon-\u03b1 on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients","volume":"8","author":"Khunger","year":"2019","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0231","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008386","article-title":"Cryoablation triggers type I interferon-dependent antitumor immunity and potentiates immunotherapy efficacy in lung cancer","volume":"12","author":"Gu","year":"2024","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.neo.2026.101348_bib0232","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101292","article-title":"Targeting CLK1\/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy","volume":"83","author":"Zhang","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"18","key":"10.1016\/j.neo.2026.101348_bib0233","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0234","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12929-025-01192-0","article-title":"CXCL5 neutralization mitigates cancer cachexia by disrupting CAF-cancer cell crosstalk","volume":"32","author":"Kim","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neo.2026.101348_bib0236","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2026.112398","article-title":"ADAM12-programmed ECM-CAF remodeling activates PI3K-AKT and enforces an immune-excluded microenvironment to drive bladder cancer progression and therapy resistance","volume":"142","author":"Song","year":"2026","journal-title":"Cell Signal."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0237","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2330194","article-title":"Co-inhibition of TGF-\u03b2 and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance","volume":"13","author":"Nair","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.neo.2026.101348_bib0238","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115193","article-title":"Antigen-presenting CAFs orchestrate immunosuppressive niches via CXCL13-mediated immune cell infiltration dysregulation and prognostic stratification in triple-negative breast cancer","volume":"162","author":"Tian","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"33","key":"10.1016\/j.neo.2026.101348_bib0239","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202508095","article-title":"CXCL13 expression promotes CAR T cell antitumor activity and potentiates response to PD-1 blockade","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0240","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1038\/s41598-023-29450-x","article-title":"Prostate cancer cell-platelet bidirectional signaling promotes calcium mobilization, invasion and apoptotic resistance via distinct receptor-ligand pairs","volume":"13","author":"Garofano","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0241","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41467-025-68018-3","article-title":"Intratumoral delivery of FLT3L with CXCR3\/CCR5 ligands promotes XCR1(+) cDC1 infiltration and activates anti-tumor immunity","volume":"17","author":"Gorline","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0242","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004561","article-title":"Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1\/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies","volume":"10","author":"Minnar","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"30","key":"10.1016\/j.neo.2026.101348_bib0243","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500225","article-title":"Nanoparticle-mediated CXCL12-CXCR4 inhibition reprograms macrophages and suppresses gastric carcinoma","volume":"12","author":"Cao","year":"2025","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0244","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.gastro.2024.02.025","article-title":"TGF-\u03b21-induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD-L1 and CXCL12","volume":"167","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.neo.2026.101348_bib0245","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.3390\/cells11213340","article-title":"CXCR4-CXCL12-CXCR7 and PD-1\/PD-L1 in pancreatic cancer: CXCL12 predicts survival of radically resected patients","volume":"11","author":"D\u2019Alterio","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neo.2026.101348_bib0246","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","article-title":"Pillarisetty VG: the CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies","volume":"65","author":"Daniel","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0247","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1038\/s41467-025-59972-z","article-title":"CXCR4(+) mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101348_bib0248","article-title":"CXCL12\/CXCR4 axis governs treg spatial dominance over CD8+ T cells via IL-2 sequestration: a dual therapeutic target in prostate cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0249","article-title":"Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis","volume":"6","author":"Shen","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105606","article-title":"Targeting CXCL12-CXCR4 signaling enhances immune checkpoint blockade therapy against triple negative breast cancer","volume":"157","author":"Lu","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0251","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/2326-6066.CIR-24-1194","article-title":"USP15 Facilitates colorectal cancer immune evasion through SMYD3\/CCL2-dependent myeloid-derived suppressor cell recruitment","volume":"13","author":"Han","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"17","key":"10.1016\/j.neo.2026.101348_bib0252","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.7150\/thno.101575","article-title":"SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3\/CCL2\/IL-6 axis and is regulated by VEZF1","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0253","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-025-03263-0","article-title":"Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion","volume":"26","author":"Cheng","year":"2025","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0254","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13058-023-01684-7","article-title":"Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3\/AKT pathways","volume":"25","author":"Chuangchot","year":"2023","journal-title":"Breast. Cancer Res."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0255","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013175","article-title":"Oncolytic virus-induced IL-1\u03b2(+) monocyte-IL-6(+) CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer","volume":"13","author":"Li","year":"2025","journal-title":"J. ImmunOther Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0256","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2146860","article-title":"Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-\u03b2\/IL-6 pathway in neuroblastoma","volume":"11","author":"Louault","year":"2022","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0257","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1186\/s12967-024-06018-5","article-title":"Single-cell and spatial transcriptomics reveal SPP1-CD44 signaling drives primary resistance to immune checkpoint inhibitors in RCC","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0258","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156674","article-title":"Tetrahydrocurcumin alleviates colorectal tumorigenesis by modulating the SPP1\/CD44 axis and preventing M2 tumor-associated macrophage polarization","volume":"141","author":"Zhou","year":"2025","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0259","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112655","article-title":"YAP\/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-tgf\u03b2 signaling to facilitate PD-L1 expression in M2-like TAMs","volume":"405","author":"Du","year":"2021","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0260","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12967-025-06485-4","article-title":"scRNA-seq reveals that VEGF signaling mediates the response to neoadjuvant anlotinib combined with PD-1 blockade therapy in non-small cell lung cancer","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0261","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00262-020-02676-8","article-title":"Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer","volume":"70","author":"Min","year":"2021","journal-title":"Cancer Immunol. Immunther."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0262","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1038\/s41467-023-43548-w","article-title":"ID1 expressing macrophages support cancer cell stemness and limit CD8(+) T cell infiltration in colorectal cancer","volume":"14","author":"Shang","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0263","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41556-025-01840-5","article-title":"SLC2A1(+) tumour-associated macrophages spatially control CD8(+) T cell function and drive resistance to immunotherapy in non-small-cell lung cancer","volume":"28","author":"Wang","year":"2026","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0264","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","article-title":"FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity","volume":"82","author":"Yang","year":"2025","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0265","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7150\/ijbs.86085","article-title":"VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"110","key":"10.1016\/j.neo.2026.101348_bib0266","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp3978","article-title":"Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer","volume":"10","author":"Hogg","year":"2025","journal-title":"Sci. Immunol."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0267","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ccell.2025.07.013","article-title":"Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer","volume":"43","author":"Osorio","year":"2025","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0268","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011564","article-title":"ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis","volume":"13","author":"Herbrich","year":"2025","journal-title":"J. ImmunOther Cancer"},{"key":"10.1016\/j.neo.2026.101348_bib0269","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.04.013","article-title":"Tumor-infiltrating mast cells stimulate ICOS(+) regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression","volume":"57","author":"Lv","year":"2024","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2025.11.020","article-title":"Positioning and reversible suppression of CCR7(+) dendritic cells in perivascular tumor niches shape cancer immunity","volume":"59","author":"Zitti","year":"2026","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0271","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/1078-0432.CCR-25-0471","article-title":"Discovery of BMS-986365, a first-in-class dual androgen receptor ligand-directed degrader and antagonist, for the treatment of advanced prostate cancer","volume":"32","author":"Nayak","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101348_bib0272","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101195","article-title":"Cancer-associated VEGFR2(R1032Q) sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts","volume":"67","author":"Ravelli","year":"2025","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0273","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neo.2026.101348_bib0274","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216510","article-title":"TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer","volume":"581","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0275","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2024.01.008","article-title":"SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion","volume":"187","author":"Leuzzi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101348_bib0276","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2019.11.003","article-title":"Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer","volume":"142","author":"Jang","year":"2020","journal-title":"RadiOther Oncol."},{"key":"10.1016\/j.neo.2026.101348_bib0277","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1557461","article-title":"Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1\/PD-L1 therapy","volume":"16","author":"Liao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101348_bib0278","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115320","article-title":"Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer","volume":"219","author":"Steger","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0279","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/1078-0432.CCR-25-2566","article-title":"Acquired high tumor mutational burden and activity of immunotherapy after targeted therapy in microsatellite stable colorectal cancer","volume":"32","author":"Yeh","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0280","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ccell.2023.09.006","article-title":"Loss of p53 and mutational heterogeneity drives immune resistance in an autochthonous mouse lung cancer model with high tumor mutational burden","volume":"41","author":"Zhu","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0281","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/2159-8290.CD-24-0991","article-title":"Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma","volume":"15","author":"Hugaboom","year":"2025","journal-title":"Cancer Discov."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0282","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181517","article-title":"ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non-small cell lung cancer","volume":"135","author":"Jiao","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0283","article-title":"Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0284","article-title":"Berberine derivative B68 promotes tumor immune clearance by dual-targeting BMI1 for senescence induction and CSN5 for PD-L1 degradation","volume":"12","author":"Hu","year":"2025","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0285","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007627","article-title":"PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK\/NF-\u03bab pathway and PD-L1 expression","volume":"11","author":"Zhang","year":"2023","journal-title":"J. ImmunOther Cancer"},{"issue":"16","key":"10.1016\/j.neo.2026.101348_bib0286","doi-asserted-by":"crossref","DOI":"10.3390\/cells13161334","article-title":"Cancer-associated-fibroblast-mediated paracrine and autocrine SDF-1\/CXCR4 signaling promotes stemness and aggressiveness of colorectal cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.neo.2026.101348_bib0287","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/cells14181482","article-title":"Targeting the CXCR4\/CXCL12 axis to overcome drug resistance in triple-negative breast cancer","volume":"14","author":"Singh","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0288","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1038\/s41467-024-54129-w","article-title":"Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine sirp\u03b3-derived CD47 blocker","volume":"15","author":"Martins","year":"2024","journal-title":"Nat. Commun."},{"issue":"Pt 2","key":"10.1016\/j.neo.2026.101348_bib0289","article-title":"Enhanced cytotoxicity in multiple myeloma via T cells armed with bispecific T cell engager targeting B-cell maturation antigen on cancer cells and CD3 on T cells","volume":"143","author":"Supimon","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0290","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41467-025-67344-w","article-title":"Lypd6b depletion promotes CD8(+) T cell-mediated anti-tumor immunity via metabolic reprogramming in colorectal cancer","volume":"17","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0291","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/0008-5472.CAN-23-0966","article-title":"FASN inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma","volume":"84","author":"Huang","year":"2024","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101348_bib0292","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"issue":"43","key":"10.1016\/j.neo.2026.101348_bib0293","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403629","article-title":"Increases in 4-acetaminobutyric acid generated by phosphomevalonate kinase suppress CD8(+) T cell activation and allow tumor immune escape","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neo.2026.101348_bib0294","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218359","article-title":"Emerging biomarkers in melanoma: bridging molecular discovery and precision oncology","volume":"645","author":"Xu","year":"2026","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0295","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","article-title":"The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer","volume":"56","author":"Taifour","year":"2023","journal-title":"Immunity"},{"issue":"44","key":"10.1016\/j.neo.2026.101348_bib0296","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407506121","article-title":"QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion","volume":"121","author":"Wei","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0297","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","article-title":"Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade","volume":"72","author":"Conche","year":"2023","journal-title":"Gut"},{"issue":"683","key":"10.1016\/j.neo.2026.101348_bib0298","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3558","article-title":"Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.neo.2026.101348_bib0299","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.7150\/thno.52435","article-title":"ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.neo.2026.101348_bib0300","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.142","article-title":"PD-L1(+) macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy","volume":"8","author":"Hirayama","year":"2024","journal-title":"Hemasphere"},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0301","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/2159-8290.CD-24-1232","article-title":"Tumor-associated NK cells regulate distinct CD8+ T-cell differentiation program in cancer and contribute to resistance against immune checkpoint blockers","volume":"15","author":"Song","year":"2025","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0302","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2034257","article-title":"Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1\/PD-L1 blockade immunotherapeutic response in cervical cancer","volume":"11","author":"Wang","year":"2022","journal-title":"Oncoimmunology"},{"issue":"15","key":"10.1016\/j.neo.2026.101348_bib0303","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191119","article-title":"A CD4+ T lymphocyte-specific TCR\/GSDMD\/IL-2 axis facilitates antitumor immunity","volume":"135","author":"Yao","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.neo.2026.101348_bib0304","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut. Microbes"},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13046-024-03080-1","article-title":"PI3K\u03b3 inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer","volume":"43","author":"Curcio","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0306","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2600701","article-title":"PI3K\u03b3 inhibition drives M1 macrophage differentiation and synergizes with PD-L1 blockade to improve survival in poorly immunogenic head and neck squamous cell carcinoma","volume":"27","author":"Jordanides","year":"2026","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0307","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/gutjnl-2024-333492","article-title":"Induction of macrophage efferocytosis in pancreatic cancer via PI3K\u03b3 inhibition and radiotherapy promotes tumour control","volume":"74","author":"Russell","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.neo.2026.101348_bib0308","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110440","article-title":"Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3K\u03b3","volume":"129","author":"Yuan","year":"2020","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.neo.2026.101348_bib0309","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114212","article-title":"Chemotherapy boosts anti-angiogenic and anti-PD-1 combination therapy through activation of cCAS-STING pathway in colon cancer","volume":"149","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.neo.2026.101348_bib0310","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302787","article-title":"Self-assembled acid-responsive nanosystem for synergistic anti-angiogenic\/photothermal\/ferroptosis therapy against esophageal cancer","volume":"13","author":"Li","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"10.1016\/j.neo.2026.101348_bib0311","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1158\/2159-8290.CD-21-1248","article-title":"Single-cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer","volume":"12","author":"Schalck","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0312","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.neo.2026.101348_bib0313","article-title":"Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer","volume":"5","author":"Chakraborty","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101348_bib0314","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107314","article-title":"Tetrandrine activates STING\/TBK1\/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer","volume":"207","author":"Tan","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"762","key":"10.1016\/j.neo.2026.101348_bib0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj9366","article-title":"Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer","volume":"16","author":"Chibaya","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0316","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7150\/thno.101001","article-title":"A STING agonist prodrug reprograms tumor-associated macrophage to boost colorectal cancer immunotherapy","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"},{"issue":"13","key":"10.1016\/j.neo.2026.101348_bib0317","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.cell.2024.04.025","article-title":"ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity","volume":"187","author":"Maxwell","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neo.2026.101348_bib0318","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell"},{"issue":"32","key":"10.1016\/j.neo.2026.101348_bib0319","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302705","article-title":"NAT10\/ac4C\/FOXP1 Promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0320","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","article-title":"IL1R1(+) cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer","volume":"14","author":"Koncina","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0321","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13058-025-02020-x","article-title":"ESR1 testing on FFPE samples from metastatic lesions in HR\u2009+\u2009\/HER2- breast cancer after progression on CDK4\/6 inhibitor therapy","volume":"27","author":"Venetis","year":"2025","journal-title":"Breast. Cancer Res."},{"issue":"5","key":"10.1016\/j.neo.2026.101348_bib0322","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/15548627.2024.2439657","article-title":"Baicalein tethers CD274\/PD-L1 for autophagic degradation to boost antitumor immunity","volume":"21","author":"Hao","year":"2025","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.neo.2026.101348_bib0323","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00432-025-06324-5","article-title":"CAA-derived IL-6 promoted the PD-L1 expression of breast cancer via STAT3\/miR-497a-5p signaling","volume":"151","author":"Zhao","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0324","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13046-024-03122-8","article-title":"CXCL5 impedes CD8(+) T cell immunity by upregulating PD-L1 expression in lung cancer via PXN\/AKT signaling phosphorylation and neutrophil chemotaxis","volume":"43","author":"Sun","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.neo.2026.101348_bib0325","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-24-2449","article-title":"XMT-2056, a HER2-directed STING agonist antibody-drug conjugate, induces innate antitumor immune responses by acting on cancer cells and tumor-resident immune cells","volume":"31","author":"Bukhalid","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101348_bib0326","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005627","article-title":"STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer","volume":"11","author":"Ding","year":"2023","journal-title":"J. ImmunOther Cancer"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:37:24Z","timestamp":1788262644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":326,"alternative-id":["S1476558626000795"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101348","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding tumor immune microenvironment heterogeneity by single-cell and spatial multi-omics: From immunotherapy resistance to translational biomarkers","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101348"}}